paroxetine has been researched along with Menopause in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 17 (60.71) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Crandall, CJ; Manson, JE; Mehta, JM | 1 |
| Dobs, AS | 1 |
| Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ; Simon, JA | 1 |
| Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ | 1 |
| Chandler, J; Denker, AE; Gottesdiener, K; He, W; Lazarus, N; Rosenberg, E; Simon, JA; Wagner, JA | 1 |
| Handley, AP; Williams, M | 1 |
| Pines, A | 1 |
| Carris, N; Kutner, S; Reilly-Rogers, S | 1 |
| Bachmann, G | 1 |
| Champion, MN; Palmore, KB; Slaton, RM | 1 |
| Jacob, JA | 1 |
| Pinkerton, JV | 1 |
| Huang, S; Liu, C; Liu, X; Ye, Y | 1 |
| Aloisi, A; Angioli, R; Capriglione, S; Lopez, S; Luvero, D; Montera, R; Plotti, F; Scaletta, G; Serra, GB | 1 |
| Crider, M; Hill, DA; Hill, SR | 1 |
| Bazanella Sampaio, T; Mozzaquatro Gai, B; Nogueira, CW; Pinton, S; Trevisan da Rocha, J; Zeni, G | 1 |
| Beebe, KL; Dube, E; Iyengar, M; Stearns, V | 1 |
| Yonkers, KA | 1 |
| Baber, R; Hickey, M; Kwik, M | 1 |
| Albertazzi, P | 1 |
| Stearns, V | 1 |
| Alexander, IM; Moore, A | 1 |
| Ikeda, A; Ueki, M; Ushiroyama, T | 1 |
| Egawa, T; Ikeda, M; Kataoka, Y; Koga, A; Shuto, H; Sohda, Y; Tominaga, K; Yamauchi, A | 1 |
| Amsterdam, JD; Garcia-España, F; Goodman, D; Hooper, M; Hornig-Rohan, M | 1 |
| Crawford, J; Ellis, MJ; Hanfelt, JJ; Hayes, DF; Isaacs, C; Kramer, R; Lawrence, W; Rowland, J; Stearns, V | 1 |
9 review(s) available for paroxetine and Menopause
| Article | Year |
|---|---|
Management of Menopausal Symptoms: A Review.
Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism | 2023 |
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride | 2015 |
New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate.
Topics: Clinical Trials as Topic; Drug Combinations; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Mesylates; Paroxetine; Vasomotor System | 2014 |
A review of paroxetine for the treatment of vasomotor symptoms.
Topics: Antidepressive Agents, Second-Generation; Female; Hot Flashes; Humans; Menopause; Paroxetine | 2015 |
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride | 2016 |
Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes.
Topics: Antidepressive Agents, Second-Generation; Female; Hot Flashes; Humans; Menopause; Mood Disorders; Paroxetine; Premenstrual Syndrome | 2003 |
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2005 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.
Topics: Adrenergic alpha-Agonists; Algorithms; Amines; Citalopram; Clonidine; Complementary Therapies; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Life Style; Menopause; Middle Aged; Nurse Practitioners; Paroxetine; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Primary Health Care; Safety Management; Selective Serotonin Reuptake Inhibitors | 2007 |
7 trial(s) available for paroxetine and Menopause
| Article | Year |
|---|---|
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.
Topics: Adult; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Postmenopause; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2013 |
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.
Topics: Adult; Aged; Body Mass Index; Body Weight; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Single-Blind Method | 2014 |
Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
Topics: Adult; Double-Blind Method; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medical Records; Menopause; Middle Aged; Paroxetine; Raloxifene Hydrochloride; Reproducibility of Results; Selective Estrogen Receptor Modulators; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2014 |
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
Topics: Adult; Aged; Double-Blind Method; Female; Genital Neoplasms, Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Survivors; Treatment Outcome | 2016 |
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
Topics: Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Female; Health Status Indicators; Hot Flashes; Humans; Logistic Models; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2004 |
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Topics: Adult; Aged; Anxiety; Breast Neoplasms; Confidence Intervals; Depression; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Survivors | 2000 |
12 other study(ies) available for paroxetine and Menopause
| Article | Year |
|---|---|
A little better than placebo is still better than nothing.
Topics: Dose-Response Relationship, Drug; Female; Humans; Menopause; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration | 2013 |
Paroxetine (Brisdelle) for hot flashes.
Topics: Drug Interactions; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2013 |
Safety of low-dose paroxetine.
Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2014 |
Another option for menopausal vasomotor symptoms without negative impact on weight and sexual function.
Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2014 |
Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society.
Topics: Behavior Therapy; Cognitive Behavioral Therapy; Exercise; Female; Health Education; Hot Flashes; Humans; Menopause; Paroxetine; Practice Guidelines as Topic; Relaxation; Societies, Medical; United States; Vascular Diseases; Vasomotor System; Women's Health; Yoga | 2015 |
Can Nonhormonal Treatments Dial Down the Heat During Menopause?
Topics: Advisory Committees; Antidepressive Agents; Cognitive Behavioral Therapy; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Hypnosis; Menopause; Paroxetine; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Stellate Ganglion | 2016 |
Dose is important for nonhormonal therapy for hot flashes.
Topics: Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2016 |
Ovariectomy changes the response to antidepressant drugs in tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Doxepin; Estrogens; Female; Hindlimb Suspension; Menopause; Mice; Mice, Inbred ICR; Ovariectomy; Paroxetine; Venlafaxine Hydrochloride | 2016 |
Effects of diphenyl diselenide on depressive-like behavior in ovariectomized mice submitted to subchronic stress: involvement of the serotonergic system.
Topics: Animals; Antidepressive Agents; Benzene Derivatives; Cerebral Cortex; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Hippocampus; Immobility Response, Tonic; Menopause; Mice; Mice, Inbred Strains; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Ondansetron; Organoselenium Compounds; Ovariectomy; Pargyline; Paroxetine; Piperazines; Pyridines; Ritanserin; Serotonergic Neurons; Serotonin Antagonists; Stress, Psychological | 2012 |
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.
Topics: Antineoplastic Agents, Hormonal; Hot Flashes; Humans; Menopause; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors | 2006 |
Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice.
Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Fluvoxamine; Hot Flashes; Humans; Menopause; Mice; Mice, Inbred ICR; Models, Animal; Ovariectomy; Paroxetine; Physical Conditioning, Animal; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Tail | 2008 |
Breast enlargement during chronic antidepressant therapy.
Topics: Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Hyperplasia; Male; Menopause; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 1997 |